[{"address1": "21 Executive Blvd", "city": "Farmingdale", "state": "NY", "zip": "11735", "country": "United States", "phone": "631 755 5500", "website": "https://www.enzo.com", "industry": "Diagnostics & Research", "industryKey": "diagnostics-research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York.", "fullTimeEmployees": 125, "companyOfficers": [{"maxAge": 1, "name": "Ms. Kara  Cannon", "age": 54, "title": "CEO & Director", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 714352, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Patricia  Eckert CPA", "age": 46, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 389290, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian J. Fisher", "age": 52, "title": "General Counsel & Secretary", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "maxAge": 86400, "priceHint": 4, "previousClose": 0.7143, "open": 0.711, "dayLow": 0.7115, "dayHigh": 0.75, "regularMarketPreviousClose": 0.7143, "regularMarketOpen": 0.711, "regularMarketDayLow": 0.7115, "regularMarketDayHigh": 0.75, "dividendRate": 0.4, "dividendYield": 0.396, "exDividendDate": 1731628800, "beta": 0.729, "forwardPE": -1.8464103, "volume": 134109, "regularMarketVolume": 134109, "averageVolume": 144925, "averageVolume10days": 350940, "averageDailyVolume10Day": 350940, "bid": 0.71, "ask": 0.745, "bidSize": 3100, "askSize": 800, "marketCap": 37620976, "fiftyTwoWeekLow": 0.68, "fiftyTwoWeekHigh": 1.44, "priceToSalesTrailing12Months": 1.1790822, "fiftyDayAverage": 1.0096, "twoHundredDayAverage": 1.1006, "currency": "USD", "enterpriseValue": 3904514, "profitMargins": -0.81731004, "floatShares": 35036443, "sharesOutstanding": 52244100, "sharesShort": 421877, "sharesShortPriorMonth": 477483, "sharesShortPreviousMonthDate": 1730332800, "dateShortInterest": 1732838400, "sharesPercentSharesOut": 0.0081, "heldPercentInsiders": 0.21574, "heldPercentInstitutions": 0.31789, "shortRatio": 2.8, "shortPercentOfFloat": 0.009, "impliedSharesOutstanding": 52244100, "bookValue": 1.074, "priceToBook": 0.6704842, "lastFiscalYearEnd": 1722384000, "nextFiscalYearEnd": 1753920000, "mostRecentQuarter": 1722384000, "netIncomeToCommon": -9817000, "trailingEps": -0.15, "forwardEps": -0.39, "lastSplitFactor": "105:100", "lastSplitDate": 1098316800, "enterpriseToRevenue": 0.122, "enterpriseToEbitda": -0.352, "52WeekChange": -0.49285716, "SandP52WeekChange": 0.25443196, "lastDividendValue": 0.04701, "lastDividendDate": 804384000, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "ENZ", "underlyingSymbol": "ENZ", "shortName": "Enzo Biochem, Inc.", "longName": "Enzo Biochem, Inc.", "firstTradeDateEpochUtc": 329664600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "016858fb-364f-319e-b570-8dbd2241729c", "messageBoardId": "finmb_269828", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.7201, "recommendationKey": "none", "totalCash": 52371000, "totalCashPerShare": 1.002, "ebitda": -11093000, "totalDebt": 3509000, "quickRatio": 2.273, "currentRatio": 2.825, "totalRevenue": 31907000, "debtToEquity": 6.254, "revenuePerShare": 0.627, "returnOnAssets": -0.074439995, "returnOnEquity": -0.1459, "freeCashflow": -18948250, "operatingCashflow": -26259000, "grossMargins": 0.45858002, "ebitdaMargins": -0.34767, "operatingMargins": -0.38752997, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-01-02"}]